About Marker Gene Technologies
Marker Gene Technologies is a Healthcare company based in Eugene (United States) founded in 1993, and was acquired by Abcam in March 2020. It develops kits and reagents for research application. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Probes and Dyes. Its competitors include BioLife Solutions, RoosterBio and Nanosphere; 2 of its 3 listed competitors have raised funding.
Company details
Marker Gene Technologies offers reagents and kits for life science research application. The product line includes MarkerGene Kits, Enzyme Assays, Plant Molecular Biology, Labeling Reagents, New Products, Cell Biology, Reporter Assays, and Biological Probes.
- Headquarters Eugene, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website markergene.com
- Social LinkedIn X Facebook
- Acquired by Abcam (Mar 2020)
Funding Insights of Marker Gene Technologies
- Total Rounds 3
- Last Round Grant — $224,593
- First Round $99,959
(Oct 2007)
- Investors Count 2
All 3 funding rounds of Marker Gene Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2016 | $224,593 | Grant | – | – | |
| Aug 2009 | $799,858 | Grant | – | – | |
| Oct 2007 | $99,959 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Marker Gene Technologies
Marker Gene Technologies has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Abcam, SBIR and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Biological reagents and antibodies are developed for life science research. | 1998 | abcam.com | Cambridge, United Kingdom |
Investor details for Marker Gene Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Marker Gene Technologies
4 dated milestones of Marker Gene Technologies across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Marker Gene Technologies is founded.
- Funding First funding round of $100K.
- Funding Latest funding round, Grant, of $225K.
- Exit Acquired by Abcam.
Competitors of Marker Gene Technologies
Marker Gene Technologies has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and Nanosphere.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| nanosphere.us | 1999 | Northbrook, United States | $97.75M | 146 | Diagnostic tests for personalized medicine targeting infections are provided. |
Detailed competitors of Marker Gene Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Marker Gene Technologies
Websites that share an audience with Marker Gene Technologies (markergene.com).
Websites whose visitors overlap most with Marker Gene Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
creative-biogene.com | creative-biogene.com | 100% | #888,012 | – | |
| genecopoeia.com | 96% | 17.2K | #1,512,108 | View details | |
ecoliwiki.net | ecoliwiki.net | 96% | – | ||
| invivogen.com | 95% | #465,301 | View details | ||
springerprotocols.com | springerprotocols.com | 95% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Marker Gene Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Marker Gene Technologies (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Marker Gene Technologies
Complete news archive for Marker Gene Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marker Gene Technologies
Marker Gene Technologies was founded in 1993 and raised its 1st funding round 14 years after it was founded.
Marker Gene Technologies is headquartered in Eugene, United States. It is registered at Eugene, Oregon, United States.
Marker Gene Technologies offers reagents and kits for life science research application. The product line includes MarkerGene Kits, Enzyme Assays, Plant Molecular Biology, Labeling Reagents, New Products, Cell Biology, Reporter Assays, and Biological Probes.
Marker Gene Technologies's top competitors include RoosterBio, BioLife Solutions and Nanosphere.
Marker Gene Technologies has 3 investors. Key investors include Abcam, SBIR, and National Science Foundation.
Yes. Marker Gene Technologies was acquired by Abcam in March 2020.